HomepageSHTDY • OTCMKTS
add
Sinopharm Group ADR
Vorige slotkoers
$ 12,22
Dag-range
$ 12,75 - $ 13,08
Jaar-range
$ 10,13 - $ 16,31
Beurswaarde
63,19 mld. HKD
Gem. volume
44,99K
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(CNY) | jun 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | -122,51 mld. | -0,93% |
Bedrijfskosten | -6,47 mld. | -5,44% |
Netto inkomsten | -419,63 mln. | 30,73% |
Netto winstmarge | 0,34 | -32,00% |
Winst per aandeel | — | — |
EBITDA | -2,33 mld. | 20,26% |
Effectief belastingtarief | 26,07% | — |
Balans
Totale activa
Totale passiva
(CNY) | jun 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 8,62 mld. | -74,94% |
Totale activa | 33,55 mld. | -91,97% |
Totale passiva | 15,61 mld. | -94,87% |
Totaal aandelenvermogen | 17,94 mld. | — |
Uitstaande aandelen | 3,12 mld. | — |
Koers-boekwaardeverhouding | 2,36 | — |
Rendement op activa | -2,64% | — |
Rendement op kapitaal | -5,30% | — |
Kasstroom
Nettomutatie in liquide middelen
(CNY) | jun 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | -419,63 mln. | 30,73% |
Operationele kasstroom | 46,42 mld. | 14,53% |
Kasstroom uit beleggingen | -362,06 mln. | 22,79% |
Kasstroom uit financiering | -23,30 mld. | -6,05% |
Nettomutatie in liquide middelen | 22,75 mld. | 25,76% |
Vrije kasstroom | 103,16 mld. | 370,65% |
Over
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Opgericht
2003
Website
Werknemers
113.635